TY - JOUR
T1 - Targeting Mitochondria for the Prevention and Treatment of Nonalcoholic Fatty Liver Disease
T2 - Polyphenols as a Non-pharmacological Approach
AU - Zapata, Jaime
AU - Castro-Sepulveda, Mauricio
AU - Soto-Alarcon, Sandra
AU - Alvarez, Daniela
AU - Bustamante, Andres
AU - Villarroel, Guiselle
AU - Gallardo, Arturo
AU - Garcia-Diaz, Diego Fernando
AU - Valenzuela, Rodrigo
AU - Echeverria, Francisca
N1 - Publisher Copyright:
© 2023 Bentham Science Publishers.
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Scope: Nonalcoholic fatty liver disease (NAFLD) has a high and growing prevalence globally. Mitochondria are fundamental in regulating cell energy homeostasis. Nevertheless, mitochondria control mechanisms can be exceeded in this context of energy overload. Damaged mitochondria worsen NAFLD progression. Diet and lifestyle changes are the main recommendations for NAFLD prevention and treatment. Some polyphenols have improved mitochondrial function in different NAFLD and obesity models. Objective: The study aims to discuss the potential role of polyphenols as a non-pharmacological approach targeting mitochondria to prevent and treat NAFLD, analyzing the influence of polyphenols' chemical structure, limitations and clinical projections. Methods: In vivo and in vitro NAFLD models were considered. Study searches were per-formed using the following keywords: nonalcoholic fatty liver disease, liver steatosis, mi-tochondria, mitochondrial activity, mitochondrial dynamics, mitochondrial dysfunction, mitochondrial morphology, mitochondrial cristae, fusion, fission, polyphenols, flavonoids, anthocyanins, AND/OR bioactive compounds. Conclusion: Polyphenols are a group of diverse bioactive molecules whose bioactive effects are highly determined by their chemical structure. These bioactive compounds could offer an interesting non-pharmacological approach to preventing and treating NAFLD, regulating mitochondrial dynamics and function. Nevertheless, the mitochondria' role in subjects with NAFLD treatment is not fully elucidated. The dosage and bioavailability of these compounds should be addressed when studied.
AB - Scope: Nonalcoholic fatty liver disease (NAFLD) has a high and growing prevalence globally. Mitochondria are fundamental in regulating cell energy homeostasis. Nevertheless, mitochondria control mechanisms can be exceeded in this context of energy overload. Damaged mitochondria worsen NAFLD progression. Diet and lifestyle changes are the main recommendations for NAFLD prevention and treatment. Some polyphenols have improved mitochondrial function in different NAFLD and obesity models. Objective: The study aims to discuss the potential role of polyphenols as a non-pharmacological approach targeting mitochondria to prevent and treat NAFLD, analyzing the influence of polyphenols' chemical structure, limitations and clinical projections. Methods: In vivo and in vitro NAFLD models were considered. Study searches were per-formed using the following keywords: nonalcoholic fatty liver disease, liver steatosis, mi-tochondria, mitochondrial activity, mitochondrial dynamics, mitochondrial dysfunction, mitochondrial morphology, mitochondrial cristae, fusion, fission, polyphenols, flavonoids, anthocyanins, AND/OR bioactive compounds. Conclusion: Polyphenols are a group of diverse bioactive molecules whose bioactive effects are highly determined by their chemical structure. These bioactive compounds could offer an interesting non-pharmacological approach to preventing and treating NAFLD, regulating mitochondrial dynamics and function. Nevertheless, the mitochondria' role in subjects with NAFLD treatment is not fully elucidated. The dosage and bioavailability of these compounds should be addressed when studied.
KW - Bioactive compounds
KW - liver steatosis
KW - mitochondrial dysfunction
KW - obesity
KW - phenolic compounds
UR - http://www.scopus.com/inward/record.url?scp=85154572388&partnerID=8YFLogxK
U2 - 10.2174/0929867329666221007115809
DO - 10.2174/0929867329666221007115809
M3 - Artículo de revisión
C2 - 36214303
AN - SCOPUS:85154572388
SN - 0929-8673
VL - 30
SP - 2977
EP - 2995
JO - Current Medicinal Chemistry
JF - Current Medicinal Chemistry
IS - 26
ER -